SomaLogic reports Q3 EPS (12c), consensus (17c)

Reports Q3 revenue $22.048M, consensus $20.47M. “We’re pleased to report another quarter of solid execution, marked by commercial and operational discipline throughout the organization,” said Adam Taich, Interim CEO of SomaLogic. “Momentum is building in our business, as highlighted by increasing commercial activity and newly expanded content with our 11K SomaScan launch. We remain excited about our ability to consistently deliver results in the attractive proteomics market.”